2012
Innovative strategies and models for r&d success: the evolving networked pharma company—aarkstore enterprise
Innovative Strategies and Models for R&D Success: The evolving networked pharma company—Aarkstore Enterprise
Aarkstore announce a new report » Innovative Strategies and Models for R&D Success: The evolving networked pharma company » through its vast collection of market research report.
Innovative Strategies and Models for R&D Success The evolving networked pharma company
Report overview
Many pharma companies are currently engaged in wide-scale R&D restructuring, adopting a biotechnological approach to drug development by establishing disease-focused R&D units, R&D spin-offs, strategic partnerships and joint ventures. This trend has been reinforced by the emergence of public/private partnerships, co-operatives and open-source research initiatives that have encouraged companies to target previously neglected disease areas such as biotherapeutics and vaccines. Emerging markets are also driving change throughout R&D, with companies increasingly internationalizing their processes to take advantage of tax incentives, government investment, cheap labor and technology specialists.
‘Innovative Strategies and Models for R&D Success’ is a new report explores how the latest pharma R&D strategies are improving productivity and containing costs. The effectiveness of new and emerging approaches to drug discovery and development are assessed, with over 40 detailed case studies of partnerships, alliances, collaborations, outsourcing and in-licensing opportunities. This report also explores the potential benefits and disadvantages of key offshore markets including China, India and Russia and examines the recent internal restructurings of major companies such as AstraZeneca, GlaxoSmithKline, Pfizer and Roche.
Use over 40 detailed case studies to assess new R&D approaches, and identify which strategies are most effective for different company sizes, therapeutic area focus, product portfolios and geographical locations…
Key findings
• The pharma industry is migrating towards fully-integrated networked pharmaceutical companies (FINPCos) that can improve productivity and effectively exploit the cost-savings associated with R&D internationalization. This model maximizes investment returns through the use of innovative partnerships and strategic alliances.
• Major companies including AstraZeneca, GSK, Roche and Pfizer have recenty undertaken major R&D restructuring. Changes have typically involved strategic risk-sharing partnerships, collaborations, joint ventures, spin-offs and contract agreements.
• Big Pharma are increasingly engaging in a range of risk-sharing partnerships with academics, federal agencies, contract providers, biotechs and other pharma players. Such alliances alleviate the risks of drug discovery and can improve R&D efficiency.
• Up to 30% of clinical studies are currently outsourced, and this figure will rise to 50% by 2010. This growth will be driven by companies consolidating their focus upon core competencies while contracting out secondary R&D programs to specialists.
• Virtual pharma models can reduce drug development costs by at least 25% and development times by up to 50%. Niche pharma companies have emerged to add value through strategic outsourced clinical developments that are out-licensed to established players.
Key questions answered
• What are public private partnerships and how can they be used to expand R&D programs?
• How will private federal partnerships improve technology transfer to the industry?
• To what extent can R&D outsourcing reduce development times and contain costs?
• Who are the key contract service providers in the emerging markets and what R&D related services do they offer?
• Which alternative R&D strategies are being used to attract investment and drive product development?
• How can pharma companies most effectively ensure shareholder value in the future?
Key issues examined by this report
• Benefits of R&D restructuring. The redesign of pharma R&D models within large companies is creating an entrepreneurial environment that enhances the flow of information and facilitates faster decision-making during product development. Strategic networking is also helping companies to expand their portfolios and develop a new generation of progressive blockbusters.
• New R&D approaches reduce consolidation. Innovative R&D strategies such as risk-sharing partnerships and strategic/tactical outsourcing are helping to combat the declining levels of productivity that are driving industrial consolidation.
• Role of ‘R&D spin-offs’. R&D spin-offs enable pharma companies to streamline their portfolios and reduce overheads, whilst retaining the option to license back successful candidates at a future date. The speed of product development can also be significantly improved away from internal pharma processes.
• Influence of emerging markets. Offshore R&D investments in emerging countires are becoming increasingly attractive following the lifting of WTO restrictions, tightened IP protections, infrastructure improvements and tax exemptions. India, China and Russia offer the most significant cost advatages.
For more information, please visit :
http://www.aarkstore.com/reports/Innovative-Strategies-and-Models-for-R-D-Success-The-evolving-networked-pharma-company-14339.html
Or email us at press@aarkstore.com or call +919272852585
Special offer till 31th Dec 2009
-
Свежие записи
- How to keep your pipes from freezing next winter
- How many shares do i need to register a company
- Investment bottelnecks removed for the mid- atlantic branch of angel investment network
- Investors are waiting for the next great business idea
- Legitimate work at home jobs — guarantees
- How much home can i buy
- Internet marketing: free advertising methods
- Inbound call center efficiency
- Laminate floor cleaning tip
- How to effectively advertise events in uk for free
- How to find the crowd in your niche market
- If you are not sure what a mailing list company is, we can help you
- How yahoo can survive its current woes
- Information about online joint ventures
- How to stop procrastination from holding you back
- Learn how to obtain peoples police public records without charge on the net
- La jolla locksmith
- How to make money from social networking
- Is 2009 a good year for buying a house
- Innovative strategies and models for r&d success: the evolving networked pharma company—aarkstore enterprise
- How to excel at the ultimate oxymoron: a recession-era corporate holiday party
- How to avoid the "poof, gone
- Leaflet printing: inspiring instant and effective promotional results
- How to cold call with integrity — the way we’ve always wanted to do cold calling
- John musca law background
- Learn what you can do to be successful in your business, even in a recession
- How secure is cloud computing
- Internet marketing in your facebook page
- How-to create a 3-tier funnel for active leveraged income for coaches
- How to be successful working from home
- Is it still a good time to buy a luxury watch
- Is your business making you sick
- Joint ventures make sense
- Keeping beauty salon clients happy — 6 ways to make every customer a repeat customer
- How to use internet marketing articlesto separate from the pack
- Know about insolvency and liquidation services
- India outsourcing accounting: a concept defining development
- Knowing the difference between formal and informal situations when writing an email
- International personal finance plc — financial analysis review—aarkstore enterprise
- Know your "best alternative to negotiated agreement"
- How to conference call
- Jilin jiangyuan to develop shale tile industry
- Integrated device technology, inc
- How retail pos software can improve your business:
- Interaction is where the outdated idea of mass marketing, advertising together with
- How to ensure a seamless change of ownership in business
- I lost my job on april fools day
- How to choose the right commercial lender and the right commercial loan
- How to get the leads you need to be successful
- It was just a misunderstanding
Архивы
- Май 2012
- Апрель 2012
- Март 2012
- Февраль 2012
- Январь 2012
- Декабрь 2011
- Ноябрь 2011
- Октябрь 2011
- Сентябрь 2011
- Август 2011
- Июль 2011
- Июнь 2011
- Май 2011
- Апрель 2011
- Март 2011
- Февраль 2011
- Январь 2011
- Декабрь 2010
- Ноябрь 2010
- Октябрь 2010
- Сентябрь 2010
- Август 2010
- Июль 2010
- Июнь 2010
- Май 2010
- Апрель 2010
- Март 2010
- Февраль 2010
- Январь 2010
- Декабрь 2009
- Ноябрь 2009
- Октябрь 2009
- Сентябрь 2009
- Август 2009
- Июль 2009
- Июнь 2009
- Май 2009
- Апрель 2009
- Март 2009
- Февраль 2009
- Январь 2009
- Декабрь 2008
- Ноябрь 2008
- Октябрь 2008
- Сентябрь 2008
- Август 2008
- Июль 2008
- Июнь 2008
- Май 2008
- Апрель 2008
- Март 2008
- Февраль 2008
- Январь 2008
Метки
air analyze bio bonus camera channel children construction consult delivery discount dream employment entertainment error finance fine format furniture host insurance light load manager master mobile national nature party payment picture plus promote reference rent repair rich school sport subject survey transport travel tv virtual